Why does nanodisc stabilization matter for membrane protein antigen production?

Nanodiscs provide a lipid bilayer environment that mimics the native membrane, promoting proper folding and stability of membrane protein antigens. This structural preservation is critical for maintaining antigenic epitopes and functional conformation. Stable antigens improve reliability in downstream binding assays and immunogenicity testing.

How does the dual-compartment dialysis device support continuous protein synthesis?

The device allows substrates like amino acids and energy molecules to diffuse from the outer chamber into the inner reaction chamber while removing inhibitory by-products. This maintains optimal conditions for prolonged transcription and translation. Continuous feeding supports extended incubation times, improving yield and consistency of nanodisc-stabilized antigens.

What quantitative outputs enable assessment of successful antigen synthesis?

Protein yield is measured through fluorescence signals from co-expressed reporters like GFP, indicating translation efficiency. Antigen incorporation into nanodiscs is assessed by solubility and stability in detergent-free conditions. These outputs provide measurable benchmarks for reaction optimization and batch-to-batch consistency.

Why are replication requirements important for cross-functional collaboration in antigen production?

Reproducible synthesis across runs ensures that antigen quality remains consistent when shared between discovery, assay development, and preclinical teams. Standardized protocols reduce variability in target engagement and screening data. This reliability supports aligned decision-making across functions and accelerates project timelines.

What statistical analysis capabilities are required before implementing this method in a discovery pipeline?

Teams must establish baseline yields and variability from control reactions to define acceptable ranges for antigen production. Statistical process control helps detect deviations in synthesis efficiency or nanodisc assembly. These analyses ensure that the method meets reproducibility thresholds needed for reliable integration into screening and validation workflows.

Synthesis of Nanodisc-Stabilized Membrane Protein Antigens Using a Cell-Free System

JoVE Encyclopedia of Experiments

Microbiology

0 views • 4:46 min • September 26th, 2025

$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Take a bacterial cell-free system that lacks intact cellular structures but retains the molecular components necessary for in vitro transcription and translation.

Introduce plasmids encoding the membrane protein antigen and the scaffold protein, along with synthetic phospholipids and polymers.

Supplement the mixture with ATP, GTP, and an amino acid mix to initiate protein synthesis.

Simultaneously, prepare a feed solution enriched with the amino acid mix.

Load the mixture into the inner chamber and the feed solution into the outer chamber of a dual-compartment dialysis device.

During incubation, the substrates diffuse from the outer to the inner chamber through the semi-permeable membrane, facilitating plasmid transcription and protein translation.

The scaffold protein assembles the phospholipids and polymers into lipid nanodiscs and facilitates the folding and incorporation of MPA into these structures.

By-products generated during the reaction diffuse into the outer chamber, maintaining optimal conditions for nanodisc-stabilized MPA formation.

Prepare MOMP-tNLPs by employing a cell-free method.

Defrost the reconstitution buffer from the cell-free protein expression kit two hours before setting the reaction, and add EDTA-free protease inhibitor to the buffer. Use a kit designed to run five one-milliliter reactions. For each one-milliliter reaction, add 525 microliters of reconstitution buffer to the E.coli lysate bottle and roll it to dissolve.

Add 250 microliters of the reconstitution buffer to the reaction bottle containing the additive and dissolve by rolling. Next, add 8.1 milliliters of reconstitution buffer to the reaction feed bottle, and roll it to dissolve. To a bottle of amino acid mixture, add three milliliters of reconstitution buffer to dissolve it.

To another bottle of methionine, add 1.8 milliliters of reconstitution buffer, dissolve it, and store it on ice. Add 225 microliters of the reconstituted mixture, 270 microliters of the reconstituted amino acid mixture without methionine, and 30 microliters of reconstituted methionine to the E.coli lysate bottle. Further, add 400 microliters of the DMPC/telodendrimer mixture 15 micrograms of MOMP plasmid, and 0.6 micrograms of delta-49 ApoA1 to the mixture and mix it.

Aliquot 20 microliters of the total solution in a 1.5-milliliter tube For a GFP-expressing control reaction. Prepare a feed solution by adding 2.65 milliliters of the reconstituted amino acid mixture without methionine and 300 microliters of reconstituted methionine. Transfer one milliliter of the reaction solution to the inner reaction chamber in the cell-free reaction kit and seal it.

Related Videos

0 Views

Last updated: 4 July 2026

Synthesis of Nanodisc-Stabilized Membrane Protein Antigens Using a Cell-Free System

Overview

Key Study Components

Area of Science

Background

Purpose of Study

Methods Used

Main Results

Conclusions

Frequently Asked Questions

Executive Industry Relevance

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

Screening & Assay Development

Translational & Preclinical Research

Pipeline & Workflow Integration

Operational & Enterprise Impact

Implementation Considerations

Biopharma FAQs

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle (VLP)-Based Vaccines Using a Capture Assay

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

A Step-by-step Method for the Reconstitution of an ABC Transporter into Nanodisc Lipid Particles

Generation, Purification, and Characterization of Cell-invasive DISC1 Protein Species

Method to Visualize and Analyze Membrane Interacting Proteins by Transmission Electron Microscopy

Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation

PeptiQuick, a One-Step Incorporation of Membrane Proteins into Biotinylated Peptidiscs for Streamlined Protein Binding Assays

Native Cell Membrane Nanoparticles System for Membrane Protein-Protein Interaction Analysis

Co-Translational Insertion of Membrane Proteins into Preformed Nanodiscs